Rodney E Wegner
Overview
Explore the profile of Rodney E Wegner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kite T, Yadlapalli V, Verma R, Porwal M, Herbst J, Karlovits S, et al.
Neurosurg Rev
. 2025 Mar;
48(1):290.
PMID: 40063153
Li-Fraumeni Syndrome (LFS) is a rare hereditary cancer syndrome characterized by an increased risk of early-onset and multiple tumors across various organ systems, predominantly linked to germline TP53 mutations. While...
2.
National Trends in Radiation Treatment for Small Cell Lung Cancer Brain Metastases in the Modern Era
Desai J, Rajkumar S, Shepard M, Wegner R
Adv Radiat Oncol
. 2025 Mar;
10(3):101720.
PMID: 40041762
Purpose: Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that often leads to brain metastases. Traditional treatment has largely relied on whole brain radiation therapy...
3.
Kite T, Yadlapalli V, Herbst J, Karlovits S, Wegner R, Shepard M
J Clin Neurosci
. 2025 Feb;
135:111150.
PMID: 40015114
Introduction: High-grade gliomas (WHO Grade III and IV) invariably recur. Standardized management in the recurrent setting is ill defined. Stereotactic radiosurgery (SRS) represents a non-invasive treatment modality. Evidence to date...
4.
5.
Rajkumar S, Kite T, Desai J, Lucido T, Mathieu D, Tripathi M, et al.
J Clin Neurosci
. 2024 Dec;
132():110979.
PMID: 39673841
Background: Non-small cell lung cancer (NSCLC) patients often develop brain metastases (BMs), complicating management. We have shown that increasing frailty is associated with decreased overall survival (OS) and central nervous...
6.
Marwaha A, Liang Y, Shepard M, Yu A, Karlovits S, Wegner R
J Neurooncol
. 2024 Dec;
172(1):177-183.
PMID: 39643852
Purpose/objective(s): Small cell lung cancer (SCLC) is known to have high rates of development of brain metastases. Standard treatment has been whole brain radiation therapy (WBRT) but the role for...
7.
Kite T, Jaffe S, Yadlapalli V, Verma R, Li J, Karlovits S, et al.
J Neurooncol
. 2024 Nov;
172(1):153-162.
PMID: 39607569
Purpose: Sarcomas metastasizing to the spine are a rare entity. Ideally an En-bloc resection is necessary to achieve durable local control (LC) rates. However, anatomical constraints often limit the degree...
8.
Herr S, Kite T, Vyas P, Karlovits S, Yu A, Wegner R, et al.
J Neurooncol
. 2024 Nov;
171(3):581-588.
PMID: 39543050
Purpose: Meningiomas are the most frequent primary intracranial malignancy. While surgical resection can confer long term tumor control, stereotactic radiosurgery (SRS) is often used for small, asymptomatic tumors in the...
9.
Grogan D, Dumot C, Mantziaris G, Tos S, Tewari A, Dayawansa S, et al.
Neurosurgery
. 2024 Nov;
PMID: 39508579
Background And Objectives: Stereotactic radiosurgery (SRS) represents an effective treatment for nonfunctioning pituitary adenomas (NFPAs). However, no data have yet been published regarding results of SRS on NFPAs after multiple...
10.
Aryal B, Falls S, Yin Y, Wagner P, Bartlett D, Wegner R, et al.
J Surg Oncol
. 2024 Aug;
130(8):1700-1705.
PMID: 39190497
Background And Objectives: Primary adrenal sarcoma (PAS) is an exceedingly rare malignancy with limited data available on its epidemiology, management, and outcomes. This study aimed to characterize the national incidence,...